The in vitro elution characteristics of vancomycin from tendons.
BACKGROUND
Infection after ACL reconstruction is uncommon but catastrophic. Prophylactic graft saturation in vancomycin reportedly reduces infection rates.


OBJECTIVE
We characterized vancomycin elution from soaked tendons. Specifically, the effect of rinsing was studied. We also determined how vancomycin concentration in the soak solution and tendon dimension influenced this elution rate, and examined whether the vancomycin amount released was lower than osteoblast and chondroblast toxic concentrations.


METHODS
Bovine tendons were wrapped in sterile gauze swabs presoaked with 5-, 2.5-, or 1.25-mg/mL vancomycin solutions. After 10 minutes, rinsed and unrinsed tendons were placed in 100 mL agitated 37 °C phosphate-buffered saline (PBS). One-milliliter samples taken at 10 minutes and 1, 6, 12, 24, and 72 hours were analyzed by high-performance liquid chromatography.


RESULTS
The maximum elution rate occurred between 10 minutes and 1 hour, with no lag between experiment initiation and drug appearance in the solution. Rinsing affected the initial amount in solution but had little influence on drug release after 10 minutes. Vancomycin diffusion rates were dependent on soak solution concentration at all sampling intervals. The vancomycin amount released or eluted did not increase after the 1-hour interval. At 24 hours, concentrations were 45 ± 12, 16 ± 1, and 9 ± 3 μg/mL for the 5-, 2.5-, and 1.25-mg/mL solutions, respectively. Higher elution rates were observed in larger-volume tendons.


CONCLUSIONS
Soaked tendon grafts can act as reservoirs for vancomycin, with the amount released and elution profile dependent on rinsing, tendon volume, and soak solution concentration. Vancomycin elution was lower than previously reported osteoblast and chondroblast toxicity concentrations and above the minimum inhibitory concentration for Staphylococcus.


CONCLUSIONS
Presoaking ACL reconstruction autografts with vancomycin may reduce the risk of ACL reconstruction infection without the risk of local or general toxicity.
School of Physiotherapy and Exercise Science, Griffith University, Gold Coast 4222, Australia. j.grayson@griffith.edu.au
Jane E
JE
Grayson
Gary D
GD
Grant
Shailendra
S
Dukie
Christopher J
CJ
Vertullo
D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism* / Q000494:pharmacology; D002417:Cattle; D002851:Chromatography, High Pressure Liquid; D007700:Kinetics; D013530:Surgical Wound Infection / Q000517:prevention & control; D013710:Tendons / Q000378:metabolism* / Q000637:transplantation; D014640:Vancomycin / Q000378:metabolism* / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D014640:Vancomycin
Am J Sports Med. 2007 Jul;35(7):1059-63
17369557
Clin Orthop Relat Res. 2007 Sep;462:200-6
17572634
Arthroscopy. 2000 Mar;16(2):173-7
10705329
Clin Orthop Relat Res. 1996 Dec;(333):245-51
8981903
J Antimicrob Chemother. 2001 Jul;48 Suppl 1:5-16
11420333
Am J Sports Med. 2003 May-Jun;31(3):414-8
12750136
Am J Sports Med. 2010 Feb;38(2):281-6
19915101
J Arthroplasty. 1999 Feb;14(2):209-14
10065729
Am J Sports Med. 1999 Sep-Oct;27(5):562-70
10496570
Am J Sports Med. 1997 Mar-Apr;25(2):261-7
9079185
J Pharm Biomed Anal. 1998 Apr;16(8):1281-7
9777601
Clin Orthop Relat Res. 2002 May;(398):182-8
11964649
Am J Orthop (Belle Mead NJ). 1998 Mar;27(3):201-5
9544361
Am J Orthop (Belle Mead NJ). 1998 Mar;27(3):207-10
9544362
Arthroscopy. 2006 Apr;22(4):375-84
16581449
Arthroscopy. 2008 Dec;24(12):1330-5
19038702